Skip to main content

Valeant to buy Bausch + Lomb for $8.7 billion

Canadian company Valeant Pharmaceuticals International Inc. has agreed to buy eye care products company Bausch + Lomb Holdings Inc...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.